The diminished DNA antioxidative defense of the body leads to an intensified attack of free radicals on DNA molecules and finally to the development of malignant diseases (Ames, 1989)
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have transformed the treatment of obesity and type 2 diabetes mellitus (T2DM) by mimicking endogenous GLP-1 activity, increasing glucose-dependent insulin secretion and suppressing glucagon release
Rahaman MM, Hossain R, Herrera-Bravo J, et al
After the session, she provided me with thorough aftercare instructions, which I found very helpful." Chicago, IL "I went in with no clear expectations because it isn't something that I've ever done before
High-resolution LC-MS techniques enable precise molecular weight confirmation, peptide mapping, and structural characterization of GLP-1 therapeutics